VRXI OABI veraxa Biotech announces advancement of novel bispecific antibody drug conjugate program vxa-222 from Joint Discovery collaboratio
VRXI OABI veraxa Biotech announces advancement of novel bispecific antibody drug conjugate program vxa-222 from Joint Discovery collaboration with Omniab
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.